Aljaafari MN

No ORCID on file · 1 paper in corpus
observational 2026
Neurology and therapy ·doi:10.1007/s40120-026-00961-9

INTRODUCTION: Atogepant is an oral calcitonin gene-related peptide (CGRP) receptor antagonist approved for migraine prevention; however, real-world data from the Middle East and North Africa (MENA) region remain limited. This study evaluate…